ASO Author Reflections: The Role of Surgeons and Nurse Specialists in the Mainstreaming of Genetic Testing for Breast Cancer Patients

Affiliations

¹ Division Laboratories, Pharmacy and Biomedical Genetics, Department of Genetics, University Medical Center Utrecht, Utrecht, The Netherlands.
² Division Laboratories, Pharmacy and Biomedical Genetics, Department of Genetics, University Medical Center Utrecht, Utrecht, The Netherlands. m.g.e.m.ausems@umcutrecht.nl.

Comment

Kyra Bokkers et al. Ann Surg Oncol. 2023 Jun.

. 2023 Jun;30(6):3259-3260.

doi: 10.1245/s10434-023-13269-x. Epub 2023 Feb 24.

¹ Division Laboratories, Pharmacy and Biomedical Genetics, Department of Genetics, University Medical Center Utrecht, Utrecht, The Netherlands.
² Division Laboratories, Pharmacy and Biomedical Genetics, Department of Genetics, University Medical Center Utrecht, Utrecht, The Netherlands. m.g.e.m.ausems@umcutrecht.nl.

No abstract available

Comment on

Surgical Oncologists and Nurses in Breast Cancer Care are Ready to Provide Pre-Test Genetic Counseling.
Bokkers K, Bleiker EMA, Aalfs CM, van Dalen T, Velthuizen ME, Duijveman P, Sijmons RH, Koole W, Schoenmaeckers EJP, Ausems MGEM. Bokkers K, et al. Ann Surg Oncol. 2023 Jun;30(6):3248-3258. doi: 10.1245/s10434-023-13229-5. Epub 2023 Feb 28. Ann Surg Oncol. 2023. PMID: 36853565 Free PMC article.

1. Alberty-Oller JJ, Weltz S, Santos A, et al. Adherence to NCCN guidelines for genetic testing in breast cancer patients: Who are we missing? Ann Surg Oncol. 2021;28(1):281–286. doi: 10.1245/s10434-020-09123-z. - DOI - PubMed
1. Kemp Z, Turnbull A, Yost S, et al. Evaluation of cancer-based criteria for use in mainstream BRCA1 and BRCA2 genetic testing in patients with breast cancer. JAMA Netw Open. 2019;2(5):e194428. doi: 10.1001/jamanetworkopen.2019.4428. - DOI - PMC - PubMed
1. Bokkers K, Bleiker EMA, Aalfs CM, et al. Surgical oncologists and nurses in breast cancer care are ready to provide pre-test genetic counseling. Ann Surg Oncol. 2023. 10.1245/s10434-023-13229-5. - PMC - PubMed
1. Tutt ANJ, Garber JE, Kaufman B, et al. Adjuvant olaparib for patients with BRCA1- or BRCA2-mutated breast cancer. N Engl J Med. 2021;384(25):2394–2405. doi: 10.1056/NEJMoa2105215. - DOI - PMC - PubMed
1. Bokkers K, Vlaming M, Engelhardt EG, et al. The feasibility of implementing mainstream germline genetic testing in routine cancer care-a systematic review. Cancers (Basel) 2022;14(4):1059. doi: 10.3390/cancers14041059. - DOI - PMC - PubMed